cephalosporin

Type: Keyphrase
Name: cephalosporin
First reported Sep 08 2014 - Updated Sep 08 2014 - 1 reports

Modern drugs holding up well against antibiotic-resistant microorganisms, suggests research

Antibiotic-resistant microorganisms remain susceptible to modern drugs, according to research presented at the American Society for Microbiology’s annual ICAAC meeting in Washington, DC, on 7 September 2014 [1] .Staphylococcus aureus samples showed almost ... [Published Pharmaceutical Journal - Sep 08 2014]
First reported Sep 02 2014 - Updated Sep 02 2014 - 1 reports

"Shadow" Contract Manufacturing Industry Increasing

By Kate Hammeke, Director of Marketing Intelligence, Nice InsightThe combination of increased government healthcare coverage, ballooning government debt, and massive expiry of patent protection on originator drugs has spurred an interest in sourcing generic ... [Published Life Science Leader - Sep 02 2014]
First reported Aug 27 2014 - Updated Aug 27 2014 - 1 reports

Are expired medications OK to take?

Today’s Wall Street Journal examines an age-old question : What does the expiration date on a drug mean? Is it safe to take drugs after this date? Do they still work?“The Journal piece gives some general guidelines—most of which are correct—but there ... [Published American Council On Science & Health - Aug 27 2014]
Entities: Aspirin, Antibiotic, Drugs
First reported Aug 26 2014 - Updated Aug 27 2014 - 1 reports

Sun Pharma trades higher on the bourses

Sun Pharmaceutical Industries is currently trading at Rs. 865.95, up by 12.60 points or 1.48% from its previous closing of Rs. 853.35 on the BSE.The scrip opened at Rs. 853.45 and has touched a high and low of Rs. 875.00 and Rs. 852.65 respectively. So ... [Published Arihant Capital - Aug 26 2014]
First reported Aug 26 2014 - Updated Aug 26 2014 - 1 reports

Medical Union sees LE 425 m sales from Penicillin and Cephalosporin plants

Arab Finance : Medical Union Pharmaceuticals ( MEDU) expected sales from its new Penicillin and Cephalosporin factories to be LE 350 million and LE 75 million respectively, the company said in  bourse statement on Monday.The firm will start production ... [Published 4 Traders - Aug 26 2014]
First reported Aug 25 2014 - Updated Aug 25 2014 - 1 reports

Fluctuating Trends Found in Antimicrobial Resistance

Both increasing and decreasing trends in antimicrobial resistance are reported in the National Antimicrobial Resistance Monitoring System (NARMS) 2011 Executive Report released by the FDA in August.NARMS is an ongoing collaborative effort by the FDA, ... [Published Food Quality - Aug 25 2014]
First reported Aug 24 2014 - Updated Aug 24 2014 - 1 reports

Antibiotic capsules recalled in the U.S.

Caraco Pharmaceutical Laboratories is the U.S.-based unit of Sun Pharmaceuticals. The company initiated a recall U.S. Food and Drug Administration (FDA). In total some 4 million capsules are being recalled from the market. This comprises of units of 500 ... [Published Digital Journal - Aug 24 2014]
First reported Aug 22 2014 - Updated Aug 22 2014 - 1 reports

Promoting prudent use of antibiotics: the experience from a multifaceted regional campaign in ...

Antibiotic resistance, a major public health problem, has been linked to antibiotic consumption. In Greece both consumption and resistance rates are among the highest in Europe.A multifaceted campaign targeting both physicians and parents of school children ... [Published 7thSpace - Aug 22 2014]
First reported Aug 19 2014 - Updated Aug 19 2014 - 2 reports

AstraZeneca reports top-line results from Phase 3 antibiotic trials

07:40 ET | About: AstraZeneca Group plc (AZN)AstraZeneca (NYSE:AZN) discloses top-line results from two Phase 3 clinical trials evaluating the safety and efficacy of CAZ-AVI (ceftazidime-avibactam) as a treatment for hospitalized patients with complicated ... [Published Seeking Alpha - Aug 19 2014]
First reported Aug 19 2014 - Updated Aug 19 2014 - 1 reports

Cephalosporin compound

The cephalosporin compound of formula (I) is disclosed, which exhibits antibiotic activity against Gram-negative (e.g., Pseudomonas aeruginosa) and Gram-positive (e.g., methicillin-resistant Staphylococcus aureus) bacteria. Methods of manufacturing the ... [Published Free Patents Online - Aug 19 2014]
First reported Aug 18 2014 - Updated Aug 18 2014 - 2 reports

Sun Pharma unit recalls cephalexin capsules from US: PTI

Caraco Pharmaceutical Laboratories, the US-based unit of Sun Pharmaceuticals, has initiated a recall of multiple lots of cephalexin capsules from the US market, according to a PTI report. Citing a notification by the USFDA, the report says that the recall ... [Published Business Standard India - Aug 18 2014]
First reported Aug 18 2014 - Updated Aug 18 2014 - 1 reports

Ferrate(VI) Oxidation of β-Lactam Antibiotics: Reaction Kinetics, Antibacterial Activity Changes, and Transformation Products

Oxidation of β-lactam antibiotics by aqueous ferrate(VI) was investigated to determine reaction kinetics, reaction sites, antibacterial activity changes, and transformation products. Apparent second-order rate constants (kapp) were determined in the pH ... [Published Environmental Science & Technology - Aug 18 2014]

Quotes

"In the US, readmission rates are one of the principal metrics that the Center for Medicare Services is evaluating, so anything that can have an impact on that will have a phenomenal effect"
Says a senior Maharashtra FDA official, "FDA lab investigated the samples for carrying several tests including microbiology and sterility tests. Over 50, 000 samples were distributed to 14 hospitals across the city and no such drug reaction has been reported. The incidents of adverse drug reaction were reported only in the female ward of the civic run Bhabha Hospital. Drugs are of standard quality and may be considered safe for use."
...invited in by the unsuspecting enemy bacteria and then effectively defeating it," said Dr Tsutae Den Nagata, Chief Medical Officer, Shionogi. "S-649266 is the most advanced product in our anti-infective development portfolio. We have already gained important insight from meetings with key opinion leaders in the US, Europe and Japan and are looking forward to the next stage of its development."
"Greater awareness of the urgency of the problem has given new impetus to careful stewardship of existing antibiotics. Prescribers are now heeding the warning that Fleming gave in his Nobel Prize acceptance speech - to use antibiotics judiciously or else lose them forever."

More Content

All (135) | News (113) | Reports (0) | Blogs (10) | Audio/Video (0) | Fact Sheets (11) | Press Releases (0)
sort by: Date | Relevance
Antibiotic Surveillance Reduces Readmission, St... [Published General Medicine eJournal - 11 hours ago]
Merck’s Beta-lactamase Inhibitor Relebactam Gra... [Published Drugs.com - 22 hours ago]
Lupin gains after inking pact to sell US-based ... [Published Business Standard India - Sep 15 2014]
Foster Farms Invests $75 Million in Salmonella ... [Published The Poultry Site - Sep 15 2014]
Excess antibiotic use in hospitals creates $163... [Published Examiner.com - Sep 14 2014]
Rash treatment can have long-term implications [Published Dermatology Times - Sep 13 2014]
Saving Lives, Saving Drugs and Saving Money; An... [Published Pharmacy Practice News - Sep 12 2014]
Mumbai FDA lab report says drugs with ADRs in p... [Published PharmaBiz - Sep 12 2014]
Survey assessed worldwide hospital antimicrobia... [Published Orthopedics Today - Sep 11 2014]
Shionogi announces encouraging data from bacter... [Published Individual.com - Sep 11 2014]
Shionogi announces encouraging data from bacter... [Published Individual.com - Sep 11 2014]
Weak Medicine [Published OSPIRG - Sep 11 2014]
Antimicrobial Prophylaxis for Children with Ves... [Published New England Journal of Medicine - Sep 11 2014]
An outbreak of extremely drug-resistant Pseudom... [Published BMC - Sep 10 2014]
Antibiotic resistance: how has it become a glob... [Published Medical News Today - Sep 10 2014]
RDSMY, LSTMF, Removed From Naked Short Lists Today [Published Individual.com - Sep 10 2014]
Bacteria-killing viruses seen as alternative to... [Published San Francisco Chronicle - Sep 10 2014]
Synthetic Biologics Releases New Data from C. d... [Published Individual.com - Sep 10 2014]
Vancomycin prophylaxis may reduce C. diff recur... [Published The Clinical Advisor - Sep 09 2014]
Experimental C. difficile drugs could be more e... [Published Fierce Biotech Research - Sep 09 2014]
Sulfonamides most frequently prescribed to chil... [Published Orthopedics Today - Sep 09 2014]
Melinta Therapeutics’ delafloxacin shows potent... [Published Drug Discovery News - Sep 08 2014]
Modern drugs holding up well against antibiotic... [Published Pharmaceutical Journal - Sep 08 2014]
Shionogi Presents Pre-Clinical and Phase I Resu... [Published PR Newswire: Health - Sep 08 2014]
Melinta Therapeutics Demonstrate Delafloxacin's... [Published CW Atlanta - Sep 08 2014]
New, deadly drug-resistant pathogen emerges in ... [Published Natural News - Sep 08 2014]
Side Effects of Drugs Annual, Vol 36 [Published Research and Markets - Sep 07 2014]
Synthetic Biologics Highlights New Data from C.... [Published KSFY - Sep 07 2014]
Synthetic Biologics Highlights New Data from C.... [Published Michigan Live - Sep 07 2014]
Population Pharmacokinetics of Ceftolozane/Tazo... [Published Journal of Clinical Pharmacology - Sep 06 2014]
1 2 3 4 5
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Shionogi Presents Pre-Clinical and Phase I Resu... [Published PR Newswire: Health - Sep 08 2014]
WASHINGTON, Sept. 8, 2014 /PRNewswire/ -- Findings reported at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) showed Shionogi's novel parenteral siderophore cephalosporin, S-694266, to exhibit marked potency against ...
UK: Sewage-treatment plants described as giant ... [Published H5N1 - Jul 19 2014]
Via The Independent:  Drug-resistant bacteria: Sewage-treatment plants described as giant 'mixing vessels' after scientists discover mutated microbes in British river . Excerpt: Superbugs resistant to some of the most powerful antibiotics in the medical ...
WHO warns antibiotic resistance is a “serious, ... [Published ScienceBlogs : Combined Feed - May 01 2014]
For the first time, the World Health Organization has examined antimicrobial resistance globally , and the grim findings won’t be surprising to anyone who’s been following this issue. (Last year, the US CDC and UK’s Chief Medical Officer issued ...
World: Antimicrobial resistance: Global report ... [Published ReliefWeb - Latest Updates - Apr 30 2014]
Source: World Health OrganizationCountry: World WHO’s report on antibiotic resistance reveals serious, worldwide threat to public health - Resistance to antibiotics found in all regions - New WHO report provides the most comprehensive picture of ...
World: Antimicrobial resistance: global report ... [Published ReliefWeb - Latest Updates - Apr 30 2014]
Source: World Health OrganizationCountry: World WHO’s report on antibiotic resistance reveals serious, worldwide threat to public health - Resistance to antibiotics found in all regions - New WHO report provides the most comprehensive picture of ...
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.